Praxis Precision Medicines
Praxis Precision Medicines
Explore linked clinical trials.8 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET) | central nervous system disorder, essential tremor, movement disorder, nervous system disorder | Recruiting | Phase 3 | 2026-10-06 | NCT06087276 | |
| A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine | brain disorder, central nervous system disorder, epilepsy, infantile epileptic-dyskinetic encephalopathy, nervous system disorder | Active, not recruiting | Phase 3 | 2026-08-04 | NCT07010471 | |
| Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures | brain disorder, central nervous system disorder, epilepsy, focal epilepsy, nervous system disorder | Active, not recruiting | Phase 3 | 2026-08-03 | NCT07505004 | |
| Clinical Trial of Vormatrigine in Adult Patients With Epilepsy | Epilepsy, Generalized, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Seizures, Focal, Signs and Symptoms, brain disorder, central nervous system disorder, epilepsy, epilepsy with generalized tonic-clonic seizures, nervous system disorder, visual epilepsy | Enrolling by invitation | Phase 3 | 2026-08-03 | NCT07287163 | |
| A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, central nervous system disorder, epilepsy, nervous system disorder, visual epilepsy | Recruiting | Phase 3 | 2026-08-03 | NCT07019922 | |
| A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Encephalopathy | brain disorder, central nervous system disorder, epilepsy, nervous system disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-08-03 | NCT05737784 | |
| A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE) | SCN2A Encephalopathy; SCN8A Encephalopathy | Active, not recruiting | Phase 2 / Phase 3 | 2026-01-29 | NCT05818553 | |
| An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, idiopathic generalized epilepsy, nervous system disorder, visual epilepsy | Recruiting | Phase 2 | 2025-04-03 | NCT06908356 |